P Rosel
Overview
Explore the profile of P Rosel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rosel P, Arranz B, Vallejo J, Alvarez P, Menchon J, Palencia T, et al.
J Affect Disord
. 1999 Jun;
52(1-3):225-33.
PMID: 10357037
Background: Serotonergic system alterations were studied in 51 depressed patients classified according to DSM-III-R criteria for major depression with melancholia compared to 31 healthy controls. Method: [3H]Imipramine and [3H]paroxetine binding...
12.
Arranz B, Rosel P, San L, Sarro S, Navarro M, Marcusson J
J Neural Transm (Vienna)
. 1998 Nov;
105(6-7):575-86.
PMID: 9826103
In this study, drug inhibition and saturation experiments on the binding of the highly selective 5-HT4 antagonist [3H]GR 113808 were performed in human brain membranes so as to better characterize...
13.
Rosel P, Arranz B, Vallejo J, Oros M, Crespo J, Menchon J, et al.
Psychiatry Res
. 1998 Oct;
82(3):161-70.
PMID: 9754440
Both the [3H]imipramine and [3H]paroxetine binding sites and the 5-HT2A receptor were simultaneously determined in frontal cortex, cingulate cortex, hippocampus and amygdala from 17 control subjects and 17 depressed suicide...
14.
Navarro M, Palencia T, Bonnin M, Rosel P
Clin Chem
. 1998 Aug;
44(8 Pt 1):1772-3.
PMID: 9702978
No abstract available.
15.
Huguet J, Rosel P, Bonnin M, Navarro M
Tumour Biol
. 1998 Jul;
19(4):222-8.
PMID: 9679731
We used immunological methods to determine cytosolic and nuclear steroid receptors to evaluate the advantages of nuclear receptor measurement in the selection of breast cancer patients for treatment. Around 75%...
16.
Rosel P, Menchon J, Vallejo J, Arranz B, Navarro M, Liron F, et al.
J Affect Disord
. 1997 Jun;
44(1):79-85.
PMID: 9186805
[3H]Paroxetine and [3H]imipramine binding to blood platelet membranes was simultaneously measured in 63 control subjects and 18 patients with DSM-III-R criteria for major depression with melancholia. Both binding sites showed...
17.
Machuca I, Ibanez L, Bonnin M, Rosel P, Arranz B, Navarro M
Int J Clin Lab Res
. 1997 Jan;
27(4):257-60.
PMID: 9580211
No abstract available.
18.
Rosel P, Arranz B, Vallejo J, Oros M, Menchon J, Alvarez P, et al.
J Neural Transm (Vienna)
. 1997 Jan;
104(8-9):921-9.
PMID: 9451724
Specific binding of [3H]imipramine and [3H]paroxetine was simultaneously examined in human brains (frontal cortex, temporal cortex, cingulate cortex, hypothalamus, hippocampus and amygdala) from 11 controls and 11 depressed suicide victims....
19.
Rosel P, Menchon J, Oros M, Vallejo J, Cortadellas T, Arranz B, et al.
J Neural Transm (Vienna)
. 1997 Jan;
104(1):89-96.
PMID: 9085196
The binding of 3H-paroxetine and 3H-imipramine has been compared in 17 different regions of 12 human control brains. Our findings reveal that the regional distribution is similar for both radioligands...
20.
Castaner M, Montana E, Camps I, Biarnes J, Merino J, Escriba J, et al.
Diabetes Metab
. 1996 Oct;
22(5):349-55.
PMID: 8896997
To determine the factors at diagnosis predictive of changes in residual beta-cell function and metabolic control in Type 1 diabetes, 125 patients older than 7 years of age consecutively diagnosed...